Marie Groth

Assessing the immune response to SARS-CoV-2 mRNA vaccines in siponimod-treated patients: a nonrandomized controlled clinical trial (AMA-VACC)

T. Ziemssen, T. Bopp, Benedict Rauser, 2022, Therapeutic advances in neurological disorders.

Immune Response to SARS-CoV-2 mRNA Vaccines in an Open-Label Multicenter Study in Participants with Relapsing Multiple Sclerosis Treated with Ofatumumab

T. Ziemssen, T. Bopp, B. Ettle, 2022, Vaccines.

Compensatory CSF2-driven macrophage activation promotes adaptive resistance to CSF1R inhibition in breast-to-brain metastasis.

K. Plate, M. Hegi, F. Klemm, 2021, Nature cancer.

Compensatory CSF2-driven macrophage activation promotes adaptive resistance to CSF1R inhibition in breast-to-brain metastasis

K. Plate, M. Hegi, F. Klemm, 2021, Nature Cancer.

Defective homologous recombination DNA repair as therapeutic target in advanced chordoma

C. von Kalle, S. Fröhling, R. Eils, 2019, Nature Communications.

Results on SARS-CoV-2 mRNA Vaccine Booster from an Open-Label Multicenter Study in Ofatumumab-Treated Participants with Relapsing Multiple Sclerosis

T. Ziemssen, T. Bopp, B. Ettle, 2023, Vaccines.

Results of the gErman migraine PatIent Survey on medical Care and prOPhylactic treatment Experience (EPISCOPE)

Z. Katsarava, Marc Ehrlich, Marie Groth, 2022, Scientific Reports.

Defective homologous recombination DNA repair as therapeutic target in advanced chordoma

Roland Eils, David Bonekamp, Kortine Kleinheinz, 2019, Nature Communications.